Two-Way Immunogenicity Testing on Existing Clinical Trial Sera to Confirm Immunogenicity Superiority of a NEW Vaccine Strain Versus the Prototype Strain
Contract Overview
Contract Amount: $450,052 ($450.1K)
Contractor: Seqirus Inc
Awarding Agency: Department of Health and Human Services
Start Date: 2026-04-02
End Date: 2026-11-08
Contract Duration: 220 days
Daily Burn Rate: $2.0K/day
Official Description: TWO-WAY IMMUNOGENICITY TESTING ON EXISTING CLINICAL TRIAL SERA TO CONFIRM IMMUNOGENICITY SUPERIORITY OF A NEW VACCINE STRAIN VERSUS THE PROTOTYPE STRAIN
Place of Performance
Location: North Carolina, 27540